Bristol Myers Squibb $BMY has been consolidating since ending a bull run at $66.00 per share. It has since falling back to about $59.80 and started to range between that and roughly $64.BMY Daily Chart(click to enlarge)Bulls Still in Charge:- The daily chart shows a bullish market in 2017 stalling after price tagged $66 in October. - Since then the market has been consolidating. - However, at the moment, price is still above the 200-, 100-, and 50-day simple moving averages (SMAs). - Also, note that price recently broke above a falling trendline, and even cracked the resistance at $64.- The bullish breakout was weak and price retreated from $64.- Let's monitor the $62 level now. - If price can find support around $62 and comes back to $64, I would anticipate a bullish breakout, and an eventual push to test the $66 resistance.- With the prevailing trend being bullish, I would not rely heavily on the $66 resistance, and instead anticipate a bullish breakout.